quinuclidines has been researched along with sirolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Z; Kang, Y; Li, Y; Wen, H; Zheng, J; Zhu, J | 1 |
| Hu, J; Jiang, J; Liu, H; Qing, G; Song, X; Su, H; Tu, R; Wang, J; Wang, L; Wang, T | 1 |
2 other study(ies) available for quinuclidines and sirolimus
| Article | Year |
|---|---|
Prevention of renal ischemia and reperfusion injury by penehyclidine hydrochloride through autophagy activation.
Topics: Adenine; Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Autophagy; Beclin-1; Caspase 3; Cell Proliferation; Disease Models, Animal; Ischemia; Kidney; Male; Quinuclidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sirolimus | 2020 |
Synergistic targeting of CHK1 and mTOR in MYC-driven tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Checkpoint Kinase 1; Datasets as Topic; Disease Progression; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; N-Myc Proto-Oncogene Protein; Neuroblastoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Proto-Oncogene Proteins c-myc; Quinolines; Quinuclidines; Sirolimus; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2021 |